| Detected | Trial | Change |
|---|---|---|
| 2026-06-04 | NCT07618078 Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After… |
date change Primary completion pushed: 2028-12-31 -> 2031-12-31 |
| 2026-06-04 | NCT07618078 Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After… |
date change Completion pushed: 2028-12-31 -> 2031-12-31 |
| 2026-05-21 | NCT07590024 RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma |
Recruitment opened |
| 2026-05-20 | NCT03583580 Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer |
date change Primary completion pushed: 2026-01 -> 2030-07 |
| 2026-05-20 | NCT03583580 Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer |
date change Completion pushed: 2026-06 -> 2031-07 |
| 2026-05-14 | NCT07395479 A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target… |
Trial arms changed: 3 -> 4 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07636824 Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and… | Phase 2 | Not Yet Recruiting |
| 2026-06-05 | NCT07630363 PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC | Phase 1/2 | Not Yet Recruiting |
| 2026-06-04 | NCT07626528 Study of Wenyang Tongbi Formula in the Treatment of Chemotherapy-Induced Polyneuropathy | Early Phase 1 | Not Yet Recruiting |
| 2026-06-01 | NCT07618078 Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After… | Recruiting | |
| 2026-05-28 | NCT07612098 Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma | Phase 2 | Not Yet Recruiting |
| 2026-05-19 | NCT07596524 Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After… | Not Yet Recruiting | |
| 2026-05-15 | NCT07590024 RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma | Phase 3 | Recruiting |
| 2026-05-14 | NCT07586657 Precision Radiotherapy for Refractory Brain Metastases: A Multicenter Study | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04821778 | Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer | Esophagus Cancer | Recruiting |
| NCT04821843 | Neoadjuvant Treatment Modalities in Esophageal Cancer | Esophageal Cancer | Recruiting |
| NCT07383246 | CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC | Medullary Thyroid Carcinoma | Recruiting |
| NCT07443397 | Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients. | Whole-Brain Radiotherapy | Recruiting |
| NCT07590024 | RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma | Nasopharyngeal Carcinoma (NPC) | Recruiting |
| NCT04320979 | Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients | Breast Cancer | Active, Not Recruiting |
| NCT07385365 | A Study of Postoperative Regional Nodal Radiotherapy in Intermediate-risk Breast Cancer | Breast Cancer | Not Yet Recruiting |
| NCT07560358 | Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III… | NSCLC (Advanced Non-small Cell Lung Cancer) | Not Yet Recruiting |
| NCT07586657 | Precision Radiotherapy for Refractory Brain Metastases: A Multicenter Study | Brain Metastasases | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT05749289 | Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression | SSTR Positive Tumors | Recruiting |
| Phase 2 | |||
| NCT07376538 | Response-Based Local Therapy for Regionally Advanced Breast Cancer | Breast Cancer | Recruiting |
| NCT07033819 | Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib | Ovarian Cancer | Recruiting |
| NCT07110103 | Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated… | SCLC | Recruiting |
| NCT07120282 | Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I… | Lung Cancer (NSCLC) | Recruiting |
| NCT07203729 | The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low… | HER2-Low Unresectable/Metastatic Breast Cancer Complicated With Visceral Crisis | Recruiting |
| NCT06761846 | Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ | Gastric Adenocarcinoma | Recruiting |
| NCT06808971 | Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative… | Gastric Adenocarcinoma | Recruiting |
| NCT06761417 | A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in… | Solid Tumors | Recruiting |
| NCT06926751 | Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced… | Solid Tumors | Recruiting |
| NCT07043894 | Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients | Solid Tumors | Recruiting |
| NCT05167994 | Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01） | Sarcoma,Soft Tissue | Recruiting |
| NCT06771609 | Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide +… | Advanced Triple-negative Breast Cancer | Recruiting |
| NCT06839560 | Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX… | Brain Metastasis From Advanced HER2-negative Breast Cancer | Recruiting |
| NCT06908668 | Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or… | HER2-Negative Locally Advanced Breast Cancer | Recruiting |
| NCT06416696 | Toripalimab for High-risk Locally Advanced Cervical Cancer | Cervical Cancers | Active, Not Recruiting |